Proteostasis Therapeutics, Inc. (PTI)

Today's Latest Price: $1.01 USD

0.01 (-0.98%)

Updated Nov 24 4:00pm

Add PTI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Proteostasis Therapeutics Inc (PTI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Proteostasis Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $4 $2 $3 $1.02 194.12%

PTI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Proteostasis Therapeutics Inc's percent of analysts bearish on the stock is less than nearly 100% of all US stocks.
  • PTI has a greater average analyst price target than 4.69% of all US stocks.
  • PTI has a higher upside potential (average analyst target price relative to current price) than 90.5% of all US stocks.
  • Proteostasis Therapeutics Inc's variance in analysts' estimates is less than 14.18% of stocks in the small market cap category.
  • Proteostasis Therapeutics Inc's number of analysts covering the stock is greater than 14.51% of Pharmaceutical Products stocks.
  • PTI has a higher percentage of analysts bullish on the stock than 81.97% of all US stocks.
  • The change in bullishness amongst analysts of PTI is less than nearly 100% of all US stocks.

Stocks similar to Proteostasis Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NBY, ONCY and EPIX.

Make investment decisions regarding PTI using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5333 seconds.